Selank 10MG
Selank is a synthetic decapeptide derived from the brain region-associated neurotrophic factor (BRANF), initially developed as a potential therapeutic agent in preclinical studies. This product is intended for research and academic purposes only. Selank’s structure and mechanism of action remain under active investigation within the scientific community.
Research Context
Selank has emerged from studies focused on its potential neuroprotective and cognitive enhancement properties. Early research suggested its involvement in the modulation of stress responses, synaptic plasticity, and neurogenesis, though its exact physiological effects are still being elucidated. The peptide’s design centers on mimicking endogenous signaling pathways to explore its potential effects in controlled laboratory settings.
Research Overview
Selank is synthesized to replicate the sequence of the first 10 amino acids of BRANF, a molecule hypothesized to play a role in brain function and resilience. Preclinical investigations have examined its effects in animal models under various conditions, including stress exposure, neuroinflammation, and cognitive challenges. While preliminary findings are encouraging, no clinical data for human application exists at this time.
Key Research Focus Areas
- Neuroprotection and Stress Response: Exploring Selank’s capacity to mitigate neuronal damage in conditions such as ischemic injury, neurodegenerative disease models, and chronic stress paradigms.
- Cognitive Enhancement: Investigating potential improvements in learning and memory performance in animal models subjected to cognitive impairment challenges.
- Synaptic Plasticity and Neurogenesis: Assessing effects on dendritic spine formation, long-term potentiation, and neurogenic processes in hippocampal regions.
- Anti-Inflammatory Mechanisms: Investigating interactions with inflammatory pathways in models of neuroinflammation, including those induced by lipopolysaccharide or amyloid-beta deposition.
- Behavioral and Emotional Modulation: Evaluating effects on anxiety-like behavior, depression-like phenotypes, and reward-related learning in preclinical studies.
Important Safety and Usage Notes
This product is intended exclusively for use in academic and research institutions by qualified personnel following approved protocols. The effects of Selank in human or animal systems are not yet characterized, and potential risks associated with its administration are unknown. Proper laboratory containment, handling procedures, and biosafety measures must be implemented during use. The peptide should be stored at recommended temperatures (typically -20°C or lower) and protected from light and moisture to maintain potency.
| Storage Instructions | Safety Considerations |
|---|---|
| Keep refrigerated at 2–8°C when not frozen. For long-term storage, transfer to a freezer at ≤ -20°C. Avoid freeze-thaw cycles. Store peptide in sealed, sterile vials to prevent contamination. | No therapeutic claims are made. Use is subject to institutional review board approval for research purposes only. |
| Do not administer to humans or animals without prior consultation with a qualified researcher or veterinarian. Containment procedures should comply with biosafety level appropriate for the study. | This product is for research and academic purposes only. Unauthorized use is prohibited. |
For research use only. Not for human or animal consumption.
Reviews
There are no reviews yet.